# PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Glioma

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06161519

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.